Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites
- 30 November 2018
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 34 (5) , 914-920
Abstract
Background and Aim: Hyponatremia is associated with development of hepatic encephalopathy (HE), but the nature of the relationship between serum sodium and HE incidence is unknown. We examined the association between serum sodium, changes in serum sodium, and HE incidence using data from three randomized trials of satavaptan in cirrhosis patients with ascites.Methods: During follow‐up, patients were examined for HE, and serum sodium was measured regularly. We used fractional polynomials to estimate the nature of the association between current serum sodium and hazard rate of HE (e.g. with a linear, logarithmic, or exponential slope) and Cox regression to adjust for confounders. Moreover, we examined the association between serum sodium at inclusion and 30‐day and 1‐year cumulative risk of HE. Finally, we examined the effect of “change in serum sodium since inclusion” on the hazard rate of HE.Results: We included 1116 patients of whom 302 developed HE. Median serum sodium at inclusion was 137 (interquartile range, 134–139). The lower the current serum sodium, the higher the rate of HE. Specifically, the confounder‐adjusted HE hazard rate increased linearly by 8% (adjusted hazard ratio = 1.08, 95% confidence interval: 1.06–1.10) for every mmol/L decrease in serum sodium over the range of measured values. Current serum sodium had a stronger effect on the HE rate than the changes in serum sodium since inclusion.Conclusion: The hazard rate of HE development increased by 8% for every mmol/L decrease in serum sodium. Further, current serum sodium had a stronger effect on the HE rate than changes in serum sodium.Keywords
Funding Information
- European Regional Development Fund
- Instituto de Salud Carlos III (PI 12/00330)
This publication has 24 references indexed in Scilit:
- Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patientsJournal of Hepatology, 2015
- Hepatic Encephalopathy2015
- Hyponatremia in Cirrhosis2015
- Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)Journal of Hepatology, 2014
- The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia – a historical cohort studyBMC Research Notes, 2012
- Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentrationLiver International, 2010
- Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent AnalysisAmerican Journal of Gastroenterology, 2009
- Review article: the burden of hepatic encephalopathyAlimentary Pharmacology & Therapeutics, 2007
- Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?Journal of Hepatology, 2000
- Portosystemic Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis: Clinical, Laboratory, Psychometric, and Electroencephalographic InvestigationsHepatology, 1998